Simplify Health Care ETF (PINK)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Simplify Health Care ETF (PINK) trades at $39.98 with AI Score 46/100 (Grade C). Simplify Health Care ETF (PINK) aims for long-term capital appreciation through investments in innovative healthcare companies. Market cap: $154.95M, Sector: Financial services.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for PINK: PINK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PINK against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
PINK: the 1 perspectives are evenly split.
How is this calculated? →Simplify Health Care ETF (PINK) Financial Services Profile
Simplify Health Care ETF (PINK) offers multi-cap exposure to pioneering biotech, medtech, and gene therapy firms. Managed by Michael Taylor, PINK distinguishes itself as a 100% pro bono ETF, allocating net profits to the Susan G. Komen foundation, thereby combining investment in healthcare innovation with charitable giving.
What Is the Investment Thesis for PINK?
Simplify Health Care ETF (PINK) presents a notable research candidate due to its focus on high-growth areas within the healthcare sector, combined with its unique pro bono structure. The ETF's multi-cap exposure allows it to capture growth across various stages of company development, from emerging biotech firms to established pharmaceutical companies. The healthcare sector is expected to continue its expansion, driven by factors such as an aging population, technological advancements, and increased healthcare spending. PINK's commitment to donating net profits to the Susan G. Komen foundation enhances its appeal to socially conscious investors. The ETF's expense ratio and tracking error relative to its benchmark will be critical factors in determining its long-term performance. The ETF's beta of 0.87 suggests lower volatility compared to the broader market, potentially making it a noteworthy option for risk-averse investors. However, the absence of a dividend yield may deter income-seeking investors.
Based on FMP financials and quantitative analysis
PINK Key Highlights
- PINK provides multi-cap exposure to innovative healthcare companies, including biotech, medtech, and gene therapy firms.
- The ETF is managed by Michael Taylor, who brings over two decades of experience managing healthcare equity portfolios.
- PINK is the first 100% pro bono ETF focused on the healthcare sector, donating net profits to the Susan G. Komen foundation.
- As of 09/01/25, PINK has donated $350,000 to the Susan G. Komen foundation.
- PINK has a beta of 0.87, indicating lower volatility compared to the broader market.
Who Are PINK's Competitors?
PINK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CLSM ETC Cabana Target Leading Sector Moderate ETF | $27.20 | +0.76% | $100.27M | 47 |
| ESG FlexShares STOXX US ESG Select Index Fund | $176.58 | +0.71% | $136.94M | 44 |
| HIDV Alliance Bernstein - AB US High Dividend ETF | $88.42 | +0.41% | $192.48M | 47 |
| IZRL ARK Israel Innovative Technology ETF | $31.49 | +2.67% | $154.77M | 47 |
| MARM FT Vest U.S. Equity Max Buffer ETF - March | $34.22 | +0.23% | $107.73M | 50 |
| NXDT NexPoint Diversified Real Estate Trust | $5.53 | +3.08% | $285.77M | 73 |
| GENB Generate Biomedicines, Inc. | $17.03 | -2.18% | $2.18B | 72 |
| SII Sprott Inc. | $118.11 | +2.72% | $3.05B | 71 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PINK's Key Strengths?
- Unique pro bono structure with donations to the Susan G. Komen foundation.
- Experienced portfolio manager with expertise in healthcare equities.
- Focus on high-growth areas within the healthcare sector.
- Multi-cap exposure provides diversification.
What Are PINK's Weaknesses?
- Relatively small market capitalization of $154.95M.
- No dividend yield may deter income-seeking investors.
- Dependence on the performance of the healthcare sector.
- Potential for higher expense ratios compared to larger ETFs.
What Could Drive PINK Stock Higher?
- Continued advancements in biotech, medtech, and gene therapy driving growth in the healthcare sector.
- Increasing demand for socially responsible investments attracting capital to PINK.
- Successful clinical trials and regulatory approvals for companies within the ETF's portfolio.
- Potential partnerships with healthcare organizations and research institutions to expand PINK's reach.
- Growing healthcare expenditure globally.
What Are the Key Risks for PINK?
- Regulatory changes impacting the healthcare industry affecting the profitability of companies within the ETF's portfolio.
- Economic downturn leading to reduced healthcare spending and lower investment returns.
- Unforeseen events such as product recalls or clinical trial failures impacting the performance of individual companies within the ETF.
- Competition from other healthcare ETFs and investment funds.
- Market volatility affecting the value of healthcare stocks.
What Are the Growth Opportunities for PINK?
- Increased Healthcare Spending: The global healthcare expenditure is projected to reach $10 trillion by 2028, driven by factors such as an aging population and the rising prevalence of chronic diseases. Simplify Health Care ETF (PINK) is well-positioned to capitalize on this trend by investing in companies that develop innovative solutions to address these healthcare challenges. The ETF's focus on biotech, medtech, and gene therapy companies aligns with the areas experiencing the most rapid growth and innovation within the healthcare sector. This growth is ongoing.
- Technological Advancements in Healthcare: Advancements in areas such as artificial intelligence, genomics, and personalized medicine are transforming the healthcare landscape. PINK's investment strategy targets companies at the forefront of these technological advancements, enabling investors to gain exposure to the potential upside of these innovations. The market for AI in healthcare, for example, is expected to reach $67 billion by 2027, presenting significant growth opportunities for companies within the ETF's portfolio. This growth is ongoing.
- Expansion of Gene Therapy Market: The gene therapy market is experiencing rapid growth, driven by the development of novel treatments for genetic disorders. PINK's focus on gene therapy companies provides investors with exposure to this high-growth area of the healthcare sector. The global gene therapy market is projected to reach $25 billion by 2028, offering substantial growth potential for companies within the ETF's portfolio. This growth is ongoing.
- Rising Demand for Medtech Solutions: The medtech industry is driven by the increasing demand for innovative medical devices and diagnostic tools. PINK's investment in medtech companies allows investors to participate in this growing market. The global medtech market is expected to reach $600 billion by 2028, fueled by factors such as an aging population and the increasing prevalence of chronic diseases. This growth is ongoing.
- Socially Responsible Investing: The growing interest in socially responsible investing (SRI) presents a unique growth opportunity for Simplify Health Care ETF (PINK). The ETF's pro bono structure, with net profits donated to the Susan G. Komen foundation, appeals to investors seeking to align their investments with their values. The SRI market is experiencing rapid growth, with assets under management exceeding $30 trillion globally. PINK's commitment to philanthropy differentiates it from other healthcare ETFs and attracts socially conscious investors. This growth is ongoing.
What Opportunities Does PINK Have?
- Growing demand for socially responsible investments.
- Expansion of the healthcare sector driven by aging population and technological advancements.
- Increasing adoption of gene therapy and personalized medicine.
- Potential for partnerships with healthcare organizations and research institutions.
What Threats Does PINK Face?
- Regulatory changes impacting the healthcare industry.
- Increased competition from other healthcare ETFs.
- Economic downturn affecting healthcare spending.
- Unforeseen events impacting the biotechnology and pharmaceutical industries.
What Are PINK's Competitive Advantages?
- First 100% pro bono ETF focused on the healthcare sector.
- Donation of net profits to the Susan G. Komen foundation.
- Experienced portfolio manager with a strong track record.
- Focus on innovative and high-growth areas within healthcare.
What Does PINK Do?
The Simplify Health Care ETF (PINK) was created to provide investors with a unique opportunity to invest in the rapidly evolving healthcare sector while simultaneously contributing to a charitable cause. The ETF focuses on long-term capital appreciation by investing in a diverse range of companies, from established pharmaceutical giants to emerging biotech startups, medtech innovators, and gene therapy pioneers. PINK's investment strategy targets multi-cap exposure, ensuring a balanced portfolio that captures growth opportunities across different market capitalizations within the healthcare industry. The ETF is managed by Michael Taylor, a seasoned portfolio manager with over two decades of experience in managing long/short healthcare equity portfolios at leading hedge funds. Taylor's expertise guides the ETF's investment decisions, leveraging his deep understanding of the healthcare landscape to identify promising investment opportunities. A key differentiator of PINK is its commitment to philanthropy. As the first 100% pro bono ETF focused on the healthcare sector, PINK donates its net profits annually to the Susan G. Komen foundation, supporting breast cancer research and awareness initiatives. As of September 1, 2025, PINK has donated $350,000. PINK operates under the ticker symbol PINK and is promoted under the tagline 'Shares for the Cure,' reflecting its dual mission of investment and charitable giving. The ETF's structure allows investors to participate in the growth of the healthcare sector while making a tangible contribution to a worthy cause. Simplify Health Care ETF presents a compelling option for investors seeking both financial returns and social impact.
What Products and Services Does PINK Offer?
- Invests in multi-cap healthcare companies.
- Focuses on biotech, medtech, and gene therapy sectors.
- Seeks long-term capital appreciation.
- Donates net profits to the Susan G. Komen foundation.
- Provides exposure to innovative healthcare companies.
- Managed by experienced portfolio manager Michael Taylor.
How Does PINK Make Money?
- Generates revenue through investment gains in healthcare companies.
- Operates as an Exchange Traded Fund (ETF).
- Attracts investors seeking exposure to the healthcare sector.
- Donates net profits to charity.
What Industry Does PINK Operate In?
The asset management industry is characterized by intense competition, with numerous ETFs and mutual funds vying for investor capital. The healthcare sector, in particular, has attracted significant investment due to its growth potential and defensive characteristics. Simplify Health Care ETF (PINK) differentiates itself through its pro bono structure and focus on innovative healthcare companies. The ETF operates in a market driven by trends such as technological advancements in medicine, increasing healthcare spending, and an aging global population. Competitors like CLSM, ESG, HIDV, IZRL, and MARM offer alternative investment options within the healthcare and ESG sectors, requiring PINK to demonstrate superior performance and social impact to attract and retain investors.
Who Are PINK's Key Customers?
- Retail investors interested in healthcare.
- Institutional investors seeking socially responsible investments.
- Investors looking for long-term capital appreciation.
- Individuals and organizations supporting breast cancer research.
How Simplify Health Care ETF Is Valued
Relative to its peer group, PINK's quantitative score of 46/100 is roughly in line with the peer average of 47/100.
PINK Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Simplify Health Care ETF's long-term potential, indicating that those closest to the company believe in its future.
- Community sentiment has shifted positively, with discussions highlighting the ETF's diversified holdings in the healthcare sector as a hedge against market volatility.
- Recent developments in healthcare policy have created a favorable environment for healthcare investments, boosting optimism among investors.
- Analysts are pointing out that the ETF's strategy aligns well with emerging trends in telehealth and biotechnology, which are gaining traction.
Bear Case
- Concerns about rising interest rates could negatively impact the healthcare sector, leading to cautious sentiment among investors.
- Some community members express skepticism about the ETF's ability to outperform traditional healthcare stocks, fearing it may lag behind in a bullish market.
- Recent regulatory changes have raised questions about the long-term viability of certain healthcare investments, causing uncertainty among traders.
- Market perception remains cautious, with discussions reflecting a belief that the ETF may face headwinds if broader market conditions deteriorate.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
PINK Latest News
No recent news available for PINK.
PINK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PINK.
Price Targets
Wall Street price target analysis for PINK.
PINK MoonshotScore
What does this score mean?
The MoonshotScore rates PINK's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
PINK Financial Services Stock FAQ
What does Simplify Health Care ETF do?
Simplify Health Care ETF (PINK) is an exchange-traded fund that seeks long-term capital appreciation by investing in a diverse portfolio of healthcare companies. The ETF focuses on innovative sectors such as biotech, medtech, and gene therapy, providing investors with exposure to cutting-edge advancements in healthcare. A unique aspect of PINK is its commitment to philanthropy, with net profits donated annually to the Susan G. Komen foundation. This structure allows investors to participate in the growth of the healthcare sector while supporting breast cancer research and awareness initiatives, combining financial returns with social impact.
What are the main risks for PINK?
Simplify Health Care ETF (PINK) faces several risks, including regulatory changes impacting the healthcare industry, economic downturns affecting healthcare spending, and unforeseen events such as product recalls or clinical trial failures. Competition from other healthcare ETFs and investment funds is also a factor. Market volatility can impact the value of healthcare stocks, and the ETF's performance is dependent on the success of its underlying investments. Investors should carefully consider these risks before investing in PINK.
How does PINK's pro bono structure impact its financial performance?
PINK's pro bono structure, where net profits are donated to the Susan G. Komen foundation, does not directly impact the ETF's investment strategy or expense ratio. The ETF aims to maximize returns through strategic investments in the healthcare sector, and the donation of net profits occurs after all operating expenses and investment management fees are covered. This structure may attract socially conscious investors, potentially increasing demand for the ETF and contributing to its long-term growth. The ETF's financial performance remains primarily driven by its investment decisions and the performance of its underlying holdings.
How sensitive is PINK to changes in healthcare policy and regulation?
Simplify Health Care ETF (PINK) is highly sensitive to changes in healthcare policy and regulation, as these factors can significantly impact the profitability and growth prospects of the companies within its portfolio. Government regulations related to drug pricing, insurance coverage, and healthcare delivery can affect the revenue and earnings of pharmaceutical, biotech, and medtech companies. Changes in regulations can create uncertainty and volatility in the healthcare sector, potentially impacting the ETF's performance. Investors should closely monitor healthcare policy developments and their potential impact on PINK's investments.
What are the key factors to evaluate for PINK?
Simplify Health Care ETF (PINK) holds an AI score of 46/100 (low). Not financial advice.
How frequently does PINK data refresh on this page?
PINK prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven PINK's recent stock price performance?
Simplify Health Care ETF (PINK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Unique pro bono structure with donations to the Susan G. Komen foundation. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider PINK overvalued or undervalued right now?
Valuing Simplify Health Care ETF (PINK) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for PINK. Further analysis is required to determine the ETF's long-term performance and risk profile.
- The information provided is based on available data and should not be considered investment advice.